These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 16401579

  • 1. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain.
    Kilic AC, Capan Y, Vural I, Gursoy RN, Dalkara T, Cuine A, Hincal AA.
    J Microencapsul; 2005 Sep; 22(6):633-41. PubMed ID: 16401579
    [Abstract] [Full Text] [Related]

  • 2. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A, Benboubetra M, Sayyed PZ, Ng KW, Fox S, Beck G, Benter IF, Akhtar S.
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [Abstract] [Full Text] [Related]

  • 3. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A, Sommer W, Fuxe K, Akhtar S.
    J Drug Target; 2000 Jul; 8(5):319-34. PubMed ID: 11328659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.
    De Rosa G, Bochot A, Quaglia F, Besnard M, Fattal E.
    Int J Pharm; 2003 Mar 18; 254(1):89-93. PubMed ID: 12615416
    [Abstract] [Full Text] [Related]

  • 6. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ, Irwin WJ, Akhtar S.
    J Drug Target; 1998 Mar 18; 5(4):291-302. PubMed ID: 9713978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y.
    J Pharm Sci; 1994 May 18; 83(5):727-32. PubMed ID: 8071830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X, Lu L, Currier BL, Windebank AJ, Yaszemski MJ.
    Biomaterials; 2002 Jul 18; 23(13):2683-92. PubMed ID: 12059017
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH, Jiang G, Jo YW, DeLuca PP.
    Pharm Res; 2001 Nov 18; 18(11):1600-6. PubMed ID: 11758769
    [Abstract] [Full Text] [Related]

  • 13. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin.
    Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y.
    Pharm Dev Technol; 2000 Nov 18; 5(1):77-85. PubMed ID: 10669921
    [Abstract] [Full Text] [Related]

  • 14. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A, Venier-Julienne MC, Saulnier P, Varlet P, Daumas-Duport C, Devauchelle P, Benoit JP.
    J Control Release; 1999 Apr 19; 58(3):311-22. PubMed ID: 10099156
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K, Yamamoto H, Hirashima N, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Mar 19; 74(3):421-6. PubMed ID: 20034563
    [Abstract] [Full Text] [Related]

  • 18. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y.
    Biomaterials; 2011 Jan 19; 32(3):870-8. PubMed ID: 20934748
    [Abstract] [Full Text] [Related]

  • 19. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP.
    J Control Release; 1999 Aug 05; 60(2-3):279-86. PubMed ID: 10425333
    [Abstract] [Full Text] [Related]

  • 20. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X, Liang S, John J, Hsiao CH, Wei X, Liang D, Xie H.
    Int J Nanomedicine; 2013 Aug 05; 8():4521-31. PubMed ID: 24311942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.